[1] WANG A,LIU X,GUO X,et al.Resting heart rate and risk of hypertension:results of the Kailuan cohort study[J].J Hypertens,2014,32(8):1600-1605;discussion1605.
[2] 李丽,黄桥梁,柳旭艳,等.中老年人群高血压的影响因素分析[J].现代医学,2024,52(3):342-349.
[3] ZHANG X,ZHANG M,LI C,et al.Associations between hypertension status and increased heart rate-China,2015[J].China CDC Wkly,2020,2(40):771-774.
[4] 孙宁玲,霍勇,黄峻.中国高血压患者心率现状调查[J].中华高血压杂志,2015,23(10):934-939.
[5] 高血压心率管理多学科共识组.中国高血压患者心率管理多学科专家共识(2021年版)[J].中国全科医学,2021,24(20):2501-2507.
[6] ZHAO M X,ZHAO Q,ZHENG M,et al.Effect of resting heart rate on the risk of all-cause death in Chinese patients with hypertension:analysis of the Kailuan follow-up study[J].BMJ Open,2020,10(3):e032699.
[7] VAN DE VEGTE Y J,EPPINGA R N,VAN DER ENDE M Y,et al.Genetic insights into resting heart rate and its role in cardiovascular disease[J].Nat Commun,2023,14(1):4646.
[8] GRASSI G,QUARTI-TREVANO F,SERAVALLE G,et al.Association between the European society of cardiology/European society of hypertension heart rate thresholds for cardiovascular risk and neuroadrenergic markers[J].Hypertension,2020,76(2):577-582.
[9] SERAVALLE G,QUARTI TREVANO F,GRASSI G.Heart rate as a predictor of cardiovascular risk[J].Minerva Med,2021,112(1):130-143.
[10] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志,2024,32(7):603-700.
[11] 中国疾病预防控制中心慢性非传染性疾病预防.中国慢性病及危险因素监测数据分析手册[M].北京:人民卫生出版社,2022.
[12] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(下)[J].中国实用内科杂志,2021,41(9):757-784.
[13] 中国血脂管理指南修订联合专家委员会,王增武,李建军,等.中国血脂管理指南(基层版2024年)[J].中国循环杂志,2024,39(4):313-321.
[14] 中国营养学会肥胖防控分会,中国营养学会临床营养分会,中华预防医学会行为健康分会,等.中国居民肥胖防治专家共识[J].中国预防医学杂志,2022,23(5):321-339.
[15] PALATINI P,DORIGATTI F,ZAETTA V,et al.Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension:the HARVEST Study[J].J Hypertens,2006,24(9):1873-1880.
[16] PALATINI P,ROSEI E A,CASIGLIA E,et al.Management of the hypertensive patient with elevated heart rate:Statement of the Second Consensus Conference endorsed by the European Society of Hypertension[J].J Hypertens,2016,34(5):813-821.
[17] 毕海涛,苏健,陈路路,等.江苏省35~75岁居民高血压患病、血压控制情况及相关因素分析[J].中华流行病学杂志,2024,45(7):947-954.
[18] 苏健,崔岚,杜文聪,等.江苏省居民高血压患病率、知晓率、治疗率和控制率分析[J].中华流行病学杂志,2019,40(9):1139-1144.
[19] 宋子伟,张梅,张笑,等.2015年我国35岁及以上高血压患者社区健康管理与高血压治疗控制情况分析[J].中华流行病学杂志,2021,42(11):2001-2009.
[20] KOLLOCH R,LEGLER U F,CHAMPION A,et al.Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease:findings from the INternational VErapamil-SR/trandolapril STudy(INVEST)[J].Eur Heart J,2008,29(10):1327-1334.
[21] XIA Y,FAN F,HUO Y,et al.Effect of baseline resting heart rate on the risk of all-cause death in Chinese patients with hypertension[J].J Clin Hypertens,2022,24(11):1473-1481.
[22] GRASSI G,DELLORO R,QUARTI-TREVANO F,et al.Sympathetic neural mechanisms in hypertension:recent insights[J].Curr Hypertens Rep,2023,25(10):263-270.
[23] 刘景超,周支军,金建荣.静息心率与2型糖尿病发病风险的关联分析[J].现代医学,2022,50(7):870-874.
[24] SERAVALLE G,GRASSI G.Sympathetic nervous system and hypertension:new evidences[J].Auton Neurosci,2022,238:102954. |